Long-Term Survival in Multiple Myeloma
- 10 February 1983
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 308 (6) , 314-316
- https://doi.org/10.1056/nejm198302103080604
Abstract
Despite the use of alkylating agents, patients with multiple myeloma have a median survival period of only two to three years.1 , 2 No series of patients with multiple myeloma surviving for more than 10 years has been reported. This review of such a group was undertaken in an effort to identify the clinical or laboratory features that suggest long-term survival. My colleagues and I found that the response to chemotherapy was the most important factor in recognizing long-term survivors.MethodsThe records of all Mayo Clinic patients given a diagnosis of multiple myeloma between January 1, 1960, and December 31, 1971 . . .This publication has 7 references indexed in Scilit:
- Epibulbar IgA Plasmacytoma Occurring in Multiple MyelomaArchives of Ophthalmology (1950), 1982
- Twenty Years Follow-Up in a Patient with Multiple MyelomaActa Haematologica, 1981
- Multiple MyelomaNew England Journal of Medicine, 1979
- Monoclonal gammopathy of undetermined significanceThe American Journal of Medicine, 1978
- Combination therapy for multiple myelomaCancer, 1977
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975